Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Loop Capital Downgrades Corteva to Hold, Raises Price Target to $71

Loop Capital Downgrades Corteva to Hold, Raises Price Target to $71

Loop Capital analyst Christopher Kapsch downgrades Corteva (NYSE:CTVA) from Buy to Hold and raises the price target from $70 to $71.

byBenzinga Newsdesk

November 15, 2022

1 minute read

Loop Capital analyst Christopher Kapsch downgrades Corteva (NYSE:CTVA) from Buy to Hold and raises the price target from $70 to $71.

These Analysts Revise Their Forecasts On Eastman Chemical After Q1 Earnings

By Avi Kapoor

April 29, 9:01 AM

Eastman Chemical (NYSE:EMN) reported better-than-expected first-quarter earnings after the closing bell on Thursday. Eastman Chemical posted adjusted earnings…

EMN

SVB Leerink Maintains Market Perform on Elevance Health, Lowers Price Target to $490

By Benzinga Newsdesk

July 22, 4:43 AM

SVB Leerink analyst Whit Mayo maintains Elevance Health (NYSE:ELV) with a Market Perform and lowers the price target from $555 to $490.

ELV

Samsung’s Latest 3D NAND Memory Chips Transform AI Data Centers and Mobile Devices

By Anusuya Lahiri

April 24, 12:47 PM

Samsung starts mass production of 286-layer NAND flash memory chips, with 33% faster data speeds and 10% lower power consumption. Big tech companies like Alphabet and Apple are major customers.

AAPL

AirSculpt Clocks 12% Sales Growth In Q2 On Higher Case Volumes

By Nabaparna Bhattacharya

August 11, 7:53 AM

AirSculpt Technologies, Inc. (NASDAQ: AIRS)

AIRS

Loop Capital Downgrades Corteva to Hold, Raises Price Target to $71

Related Posts

These Analysts Revise Their Forecasts On Eastman Chemical After Q1 Earnings

SVB Leerink Maintains Market Perform on Elevance Health, Lowers Price Target to $490

Samsung’s Latest 3D NAND Memory Chips Transform AI Data Centers and Mobile Devices

AirSculpt Clocks 12% Sales Growth In Q2 On Higher Case Volumes